Universal Beteiligungs und Servicegesellschaft mbH Acquires New Stake in Integer Holdings Co. (NYSE:ITGR)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Integer Holdings Co. (NYSE:ITGR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 59,534 shares of the medical equipment provider's stock, valued at approximately $7,889,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.18% of Integer as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Mather Group LLC. boosted its position in shares of Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in Integer during the fourth quarter worth $27,000. R Squared Ltd acquired a new stake in shares of Integer in the 4th quarter valued at $44,000. Sterling Capital Management LLC increased its stake in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares during the last quarter. Finally, Principal Securities Inc. increased its stake in shares of Integer by 31.2% in the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock valued at $85,000 after purchasing an additional 152 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently weighed in on ITGR. KeyCorp dropped their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Benchmark lowered their target price on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Raymond James increased their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Finally, Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Integer has a consensus rating of "Moderate Buy" and a consensus price target of $145.00.

Integer Trading Up 0.2%

ITGR traded up $0.25 during trading on Wednesday, reaching $120.10. 293,758 shares of the company's stock were exchanged, compared to its average volume of 374,778. The firm has a fifty day moving average price of $118.69 and a two-hundred day moving average price of $128.29. The stock has a market capitalization of $4.19 billion, a PE ratio of 35.74, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The company had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Integer's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.14 earnings per share. As a group, equities research analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.16% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.